Skip to content

Effect of Talisadi Arka and Churna in Allergic Respiratory Tract Disease

Experimental and Clinical Evaluation of Antiallergic Effect of Talishadi Churna & Talishadi Arka in Allergic Respiratory Tract Diseases. - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055367
Enrollment
118
Registered
2023-07-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J988- Other specified respiratory disorders

Interventions

None listed

Sponsors

Dean and Principal of Parul Institute of Ayurved
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients of either gender with age group 20-65 Years (both years inclusive). 2) Elevated level of IGM &IGE mild and moderate 3) Patients having clinical features of Allergic Rhinitis 4) Patients having clinical features of Bronchial asthma

Exclusion criteria

Exclusion criteria: 1) Known case of any chronic and severe systemic disorder including IHD, CVA, uncontrolled Hypertension, uncontrolled diabetes, CRF, Active Malignancy Disease. 2) Pregnant and lactating females.

Design outcomes

Primary

MeasureTime frame
Assessment on the basis of gradation criteria of bronchial asthmaTimepoint: At Baseline visit, every 15th day up to 90 days

Secondary

MeasureTime frame
Assessment on the basis of AEC, CBC, LDH, CRP, IGM & IGETimepoint: At Baseline visit and on 90th day

Countries

India

Contacts

Public ContactDr Shailesh Deshpande

Parul Institute of Ayurved

shailesh.deshpande260036@paruluniversity.ac.in9763104451

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026